Is this a piece of news regarding world politics, sports, business, or science and technology?
Corgentech treatment fails trial Shares plunge after company says its vein graft treatment failed to show benefit in late-stage test. CHICAGO (Reuters) - Biotechnology company Corgentech Inc. 
